본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

톡소플라스마 망맥락막염에서 유리체강내 클린다마이신 주입술

이용수 0

영문명
Intravitreal Clindamycin Injection for Toxoplasmic Retinochoroiditis
발행기관
대한안과학회
저자명
박수연 유호민 송지훈,Suyoun Park, MD, Ho Min Lew, MD, Ji Hun Song, MD
간행물 정보
『대한안과학회지』Ophthalmological Society,volume53,number7, 1046~1052쪽, 전체 7쪽
주제분류
의약학 > 기타의약학
파일형태
PDF
발행일자
2012.07.15
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: To present cases of toxoplasmic retinochoroiditis (TRC) treated successfully with intravitreal clindamycin injection. Case summary: (Case 1) A 41-year-old man presented with blurred left eye vision for several months. The patient had a large chorioretinal scar with infiltrations at the boundaries, and fluorescein angiography (FA) showed active retinochoroiditis. Antitoxoplasmosis (antiTX) immunoglobulin G (IgG) was positive, and the patient was started on antiTX medication. Despite several weeks of treatment with maximum doses of antiTx, the TRC progressed and visual acuity worsened. Pars plana vitrectomy (PPV) with intravitreal clindamycin injection (1.0 mg/0.1 ml) was performed, and an additional injection was given 4 weeks later. Six weeks after the second injection, TRC wascompletely resolved with 20/20 vision. (Case 2) A 67-year-old man presented with decreased left eye vision for 1 year. Fundus examinations showed vitreous opacity and epiretinal membranes. The FA revealed retinochoroiditis and the antiTX IgG titer was elevated. The presumed diagnosis was TRC, and oral medications of trimethoprim-sulfamethoxazole, clindamycin, and prednisolone was administered. Inflammation began to improve however, as the patient was not tolerating systemic antiTx medications, an intravitreal injection of clindamycin (1.0 mg/0.1 ml) was administered with PPV. The patientdiscontinued oral medication after surgery, and the inflammation resolved 5 weeks later. Conclusions: Intravitreal clindamycin injections may be an additional treatment option for TRC in patients who are unable to tolerate systemic therapy or whose disease progresses despite systemic therapy. J Korean Ophthalmol Soc 2012;53(7):1046-1052

목차

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

박수연,유호민,송지훈,Suyoun Park, MD, Ho Min Lew, MD, Ji Hun Song, MD. (2012).톡소플라스마 망맥락막염에서 유리체강내 클린다마이신 주입술. 대한안과학회지, 53 (7), 1046-1052

MLA

박수연,유호민,송지훈,Suyoun Park, MD, Ho Min Lew, MD, Ji Hun Song, MD. "톡소플라스마 망맥락막염에서 유리체강내 클린다마이신 주입술." 대한안과학회지, 53.7(2012): 1046-1052

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제